Testing effectiveness (Phase 2)Study completedNCT03712280
What this trial is testing
MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
Who this might be right for
Hepatic CirrhosisHepatic Encephalopathy (HE)
Mallinckrodt 50